Publication Details

Pubmed11090081
Title: AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
Year: 2000
First Author: Melnick
Experimental setup: affinity chromatography technology (Biogrid)
in vitro (Hprd)
in vivo (Hprd)
two hybrid (Hprd)
Throughput: Low Throughput (Biogrid)

Interactions

1 interaction
InteractorPartnerSourcesLink
MTG8_HUMANZBT16_HUMANBioGRID, HPRDdetails